BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26354034)

  • 1. De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance.
    Ohba C; Haginoya K; Osaka H; Kubota K; Ishiyama A; Hiraide T; Komaki H; Sasaki M; Miyatake S; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    J Hum Genet; 2015 Dec; 60(12):739-42. PubMed ID: 26354034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.
    Lee JR; Srour M; Kim D; Hamdan FF; Lim SH; Brunel-Guitton C; Décarie JC; Rossignol E; Mitchell GA; Schreiber A; Moran R; Van Haren K; Richardson R; Nicolai J; Oberndorff KM; Wagner JD; Boycott KM; Rahikkala E; Junna N; Tyynismaa H; Cuppen I; Verbeek NE; Stumpel CT; Willemsen MA; de Munnik SA; Rouleau GA; Kim E; Kamsteeg EJ; Kleefstra T; Michaud JL
    Hum Mutat; 2015 Jan; 36(1):69-78. PubMed ID: 25265257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity.
    Hama Y; Date H; Fujimoto A; Matsui A; Ishiura H; Mitsui J; Yamamoto T; Tsuji S; Mizusawa H; Takahashi Y
    Cerebellum; 2023 Dec; 22(6):1308-1311. PubMed ID: 36227410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
    Cai S; Li J; Wu Y; Jiang Y
    J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
    Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
    Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF1A mutation in a patient with progressive neurodegeneration.
    Okamoto N; Miya F; Tsunoda T; Yanagihara K; Kato M; Saitoh S; Yamasaki M; Kanemura Y; Kosaki K
    J Hum Genet; 2014 Nov; 59(11):639-41. PubMed ID: 25253658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
    Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
    J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy.
    Esmaeeli Nieh S; Madou MR; Sirajuddin M; Fregeau B; McKnight D; Lexa K; Strober J; Spaeth C; Hallinan BE; Smaoui N; Pappas JG; Burrow TA; McDonald MT; Latibashvili M; Leshinsky-Silver E; Lev D; Blumkin L; Vale RD; Barkovich AJ; Sherr EH
    Ann Clin Transl Neurol; 2015 Jun; 2(6):623-35. PubMed ID: 26125038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile-Onset Syndromic Cerebellar Ataxia and CACNA1G Mutations.
    Barresi S; Dentici ML; Manzoni F; Bellacchio E; Agolini E; Pizzi S; Ciolfi A; Tarnopolsky M; Brady L; Garone G; Novelli A; Mei D; Guerrini R; Capuano A; Pantaleoni C; Tartaglia M
    Pediatr Neurol; 2020 Mar; 104():40-45. PubMed ID: 31836334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.
    Cheon CK; Lim SH; Kim YM; Kim D; Lee NY; Yoon TS; Kim NS; Kim E; Lee JR
    Sci Rep; 2017 Oct; 7(1):12527. PubMed ID: 28970574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population.
    Megahed H; Nicouleau M; Barcia G; Medina-Cano D; Siquier-Pernet K; Bole-Feysot C; Parisot M; Masson C; Nitschké P; Rio M; Bahi-Buisson N; Desguerre I; Munnich A; Boddaert N; Colleaux L; Cantagrel V
    Orphanet J Rare Dis; 2016 May; 11(1):57. PubMed ID: 27146152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome.
    Langlois S; Tarailo-Graovac M; Sayson B; Drögemöller B; Swenerton A; Ross CJ; Wasserman WW; van Karnebeek CD
    Eur J Hum Genet; 2016 Jun; 24(6):949-53. PubMed ID: 26486474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases.
    Choquet K; Tétreault M; Yang S; La Piana R; Dicaire MJ; Vanstone MR; Mathieu J; Bouchard JP; Rioux MF; Rouleau GA; ; Boycott KM; Majewski J; Brais B
    Eur J Hum Genet; 2016 Jul; 24(7):1016-21. PubMed ID: 26626314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective kinesin binding of TUBB2A causes progressive spastic ataxia syndrome resembling sacsinopathy.
    Sferra A; Fattori F; Rizza T; Flex E; Bellacchio E; Bruselles A; Petrini S; Cecchetti S; Teson M; Restaldi F; Ciolfi A; Santorelli FM; Zanni G; Barresi S; Castiglioni C; Tartaglia M; Bertini E
    Hum Mol Genet; 2018 Jun; 27(11):1892-1904. PubMed ID: 29547997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up until early adulthood in autosomal dominant, complex SPG30 with a novel KIF1A variant: a case report.
    Spagnoli C; Rizzi S; Salerno GG; Frattini D; Fusco C
    Ital J Pediatr; 2019 Dec; 45(1):155. PubMed ID: 31796088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.
    Humbert J; Salian S; Makrythanasis P; Lemire G; Rousseau J; Ehresmann S; Garcia T; Alasiri R; Bottani A; Hanquinet S; Beaver E; Heeley J; Smith ACM; Berger SI; Antonarakis SE; Yang XJ; Côté J; Campeau PM
    Am J Hum Genet; 2020 Sep; 107(3):564-574. PubMed ID: 32822602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.
    Doi H; Ushiyama M; Baba T; Tani K; Shiina M; Ogata K; Miyatake S; Fukuda-Yuzawa Y; Tsuji S; Nakashima M; Tsurusaki Y; Miyake N; Saitsu H; Ikeda S; Tanaka F; Matsumoto N; Yoshida K
    Sci Rep; 2014 Nov; 4():7132. PubMed ID: 25417924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel de novo KIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, and Spastic Paraplegia.
    Kurihara M; Ishiura H; Bannai T; Mitsui J; Yoshimura J; Morishita S; Hayashi T; Shimizu J; Toda T; Tsuji S
    Intern Med; 2020 Mar; 59(6):839-842. PubMed ID: 31813911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.